...
首页> 外文期刊>Kidney international. >Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats
【24h】

Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats

机译:血管紧张素转换酶抑制剂或血管紧张素受体拮抗剂对二肾一夹高血压大鼠的慢性治疗作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats. The effects of chronic angiotensin II (Ang II) receptor blockade (losartan) or converting enzyme inhibition (enalapril) on blood pressure (BP), urinary albumin excretion (UalbV), renal histology and the hemodynamic and excretory function of the clipped and nonclipped kidneys were studied in two-kidney, one-clip (2-K 1-C) rats. One day after clipping the right renal artery, male Wistar rats were divided into three groups receiving: (1) losartan, 20 mg/kg/day (N = 7), (2) enalapril, 20 mg/kg/day (N = 8), or (3) no treatment (controls, N = 9) for three weeks. Both losartan and enalapril treatments maintained conscious BP at comparably lowered levels compared to control animals (116 6 mm Hg and 113 2 mm Hg vs. 188 11 mm Hg, respectively, P albV, observed for the untreated group, three weeks after clipping (1.7 0.5 and 0.7 0.1 mg/24 hr vs. 17.8 7 mg/24 hr, respectively, P albV for nonclipped kidneys from untreated rats was approximately 5- to 10-fold higher than in the nonclipped kidneys from the treated groups. Histological evaluation revealed evidence of early glomerulosclerosis in the nonclipped kidneys from the untreated but not the treated groups, and decreased indices of glomerular size and mesangial expansion in clipped kidneys for the treated groups compared to the untreated group. These data support a primary role for Ang II modulation of blood pressure and renal function in the nonclipped kidney of the 2-K 1-C rat.
机译:血管紧张素转化酶抑制剂或血管紧张素受体拮抗剂对两肾一夹高血压大鼠的慢性治疗效果。慢性血管紧张素II(Ang II)受体阻滞剂(氯沙坦)或转化酶抑制作用(依那普利)对血压(BP),尿白蛋白排泄(UalbV),肾脏组织学以及修剪和未修剪肾脏的血液动力学和排泄功能的影响在两肾一夹(2-K 1-C)大鼠中进行了研究。切断右肾动脉后一天,将雄性Wistar大鼠分为三组,分别为:(1)氯沙坦,20 mg / kg /天(N = 7),(2)依那普利,20 mg / kg /天(N = 8)或(3)三周未接受任何治疗(对照组,N = 9)。与对照动物相比,氯沙坦和依那普利的治疗均能使清醒的BP保持在相对较低的水平(未修剪组在修剪后三周观察到的P albV分别为116 6 mm Hg和113 2 mm Hg vs. 188 11 mm Hg(1.7分别为0.5和0.7 0.1 mg / 24 hr与17.8 7 mg / 24 hr相比,未治疗大鼠的未切除肾脏的P albV约比治疗组的未切除肾脏的P albV高5至10倍。与未治疗组相比,未治疗组(未治疗组)未切除的肾脏中早期肾小球硬化的发生率,以及未切除组肾脏的肾小球大小和系膜扩张指数降低,这些数据支持了Ang II调节血液的主要作用2-K 1-C大鼠的非唇肾的血压和肾功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号